practical considerations for durvalumab in stage 3 nsclc
Published 6 years ago • 110 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
9:57
practical considerations for immunotherapy in stage 3 nsclc
-
6:50
implications for using durvalumab in stage 3 nsclc
-
3:46
nsclc stage iii unmet needs and practical advice
-
4:25
durvalumab tolerability in non–small cell lung cancer
-
5:28
durvalumab consolidation in nsclc: the pacific trial
-
11:30
durvalumab following radiotherapy in patients with unresectable, stage 3 nsclc ineligible for ch...
-
4:13
implications of durvalumab following pacific update
-
![[lung]the role of durvalumab in patients with stage 3 lung cancer in a real hospital](https://i.ytimg.com/vi/EwpYIgllxqY/mqdefault.jpg)
3:53
[lung]the role of durvalumab in patients with stage 3 lung cancer in a real hospital
-
6:06
stage iii nsclc: when to start durvalumab
-
8:36
pacific trial: durvalumab for stage 3 nsclc
-
2:34
dr. langer on practice-changing pacific data in stage iii nsclc
-
1:18
a study of chemotherapy with durvalumab and tremelimumab in nsclc
-
2:15
accurately diagnosing unresectable stage 3 nsclc
-
5:13
effectively managing treatment with durvalumab
-
8:16
case based panel discussion - stage 3 nsclc best schedule - durvalumab/imfinzi in varying patients
-
3:07
the use of durvalumab in locally advanced nsclc
-
1:45
enhancing benefit with durvalumab in nsclc after the pacific trial
-
1:01
impact of durvalumab as consolidation therapy in nsclc
-
4:15
safety profile of durvalumab in locally advanced nsclc